Chlorhexidine

CHEMBL790 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
505.4 g/mol
LogP
0.1
Phase
4

A broad-spectrum antiseptic agent that disrupts microbial cell membranes, effective against bacteria, fungi, and some viruses, used extensively for skin and wound disinfection, hand sanitization, and oral hygiene. It binds to skin and mucous membranes for prolonged residual antimicrobial activity. It is a cornerstone of infection control protocols in healthcare settings.

分子量

505.4000 g/mol

LogP

0.10

TPSA

178.00 Ų

リピンスキーの五則

不適合

治療領域

作用機序

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1

InChI

InChI=1S/C22H30Cl2N10/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34)

Molecular Formula

C22H30Cl2N10

HBD / HBA

6 / 2

回転可能結合数

13

重原子数

34

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A broad-spectrum antiseptic agent that disrupts microbial cell membranes, effective against bacteria, fungi, and some viruses, used extensively for skin and wound disinfection, hand sanitization, and oral hygiene. It binds to skin and mucous membranes for prolonged residual antimicrobial activity. It is a cornerstone of infection control protocols in healthcare settings.

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

Yes, Chlorhexidine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL790. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9552079. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.